reports
Vital Farms Reports First Quarter 2024 Financial Results
Vital Farms Reports First Quarter 2024 Financial Results Record First Quarter Net Revenue of $147.9 million, up 24.1% versus Prior Year PeriodRaises Fiscal Year 2024 OutlookAnnounces Plans for New State-of-the-Art Egg Washing and Packing Facility AUSTIN, Texas, May 09, 2024 (GLOBE NEWSWIRE) -- Vital Farms (Nasdaq: VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today reported financial results for its first quarter ended March 31, 2024. Financial highlights for the first quarter ended March 31, 2024, compared to the first quarter ended March ...
Kingsoft Cloud to Report First Quarter 2024 Financial Results on May 2...
Kingsoft Cloud to Report First Quarter 2024 Financial Results on May 22, 2024 BEIJING, May 09, 2024 (GLOBE NEWSWIRE) -- Kingsoft Cloud Holdings Limited (NASDAQ: KC and HKEX: 3896) (“Kingsoft Cloud” or the “Company”), a leading independent cloud service provider in China, today announced that it will release its unaudited financial results for the first quarter 2024 ended March 31, 2024 before the open of U.S. markets on Wednesday, May 22, 2024. Kingsoft Cloud’s management will host an earnings conference call on Wednesday May 22, 2024 at 8:15 am, U.S. Eastern Time (8:15 pm, Beijing...
Brickability Group: 1 director
A director at Brickability Group sold 400,000 shares at 70p and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Verona Pharma Reports First Quarter 2024 Financial Results and Provide...
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update PDUFA Target Action Date for Ensifentrine of June 26, 2024 Finalizing commercial launch preparations Strong balance sheet supports commercialization and pipeline expansion Conference call today at 9:00 a.m. EDT / 2:00 p.m. BST LONDON and RALEIGH, N.C., May 09, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a biopharmaceutical company focused on respiratory diseases, announces its financial results for the first quarter ended March 31, 2024, and provi...
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Hea...
ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference LAUSANNE, Switzerland, May 09, 2024 (GLOBE NEWSWIRE) -- ADC Therapeutics SA (NYSE: ADCT) today announced that Ameet Mallik, Chief Executive Officer, will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024, at 1:35 p.m. ET. A live webcast of the presentation will be available via the Events & Presentations page in the Investors section of ADC Therapeutics’ website . A replay of the webcast will be available for approximately 30 days. A...
Bank Negara Indonesia (Persero) Tbk PT : 7 directors
Seven Directors at Bank Negara Indonesia (Persero) Tbk PT bought 1,135,000 shares at between 4,690.000IDR and 4,792.492IDR. The significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by ...
Innovent Biologics Inc: 1 director
A director at Innovent Biologics Inc sold 906,250 shares at 40.373HKD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Zhengwei Group Holdings Company Limited: 1 director
A director at Zhengwei Group Holdings Company Limited sold 90,012,000 shares at 0.152HKD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors ove...
Moody's Ratings assigns definitive ratings to Notes issued by Miltonia...
Moody's Ratings ("Moody's"), has assigned definitive long-term credit ratings to Notes issued by Miltonia Mortgage Finance S.r.l.: ....EUR3650.4M A Mortgage Backed Floating Rate Notes due April 2062, Definitive Rating Assigned Aa3 (sf) ....EUR128.3M B Mortgage Backed Floating Rate Notes due April...
Man Group PLC : Form 8.3 - Barratt Developments plc
Man Group PLC : Form 8.3 - Barratt Developments plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant secur...
Man Group PLC : Form 8.3 - Tyman plc
Man Group PLC : Form 8.3 - Tyman plc FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser:Man Group PLC(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form...
Moody's Ratings affirms Korea's Aa2 issuer rating; maintains stable ou...
Moody's Ratings ("Moody's") has today affirmed the Government of Korea's ("Korea") local and foreign currency long-term issuer ratings at Aa2 and maintained the stable outlook. The local and foreign currency senior unsecured and foreign currency senior unsecured shelf ratings were also affirmed at A...
Standard Lithium Reports Fiscal Third Quarter 2024 Results, Schedules ...
Standard Lithium Reports Fiscal Third Quarter 2024 Results, Schedules Investor Update Call STRATEGIC EXECUTION SECURES LEADING GLOBAL ENERGY PARTNER, EQUINOR. INJECTS IMMEDIATE LIQUIDITY THROUGH DIRECT INVESTMENTS IN SOUTH WEST ARKANSAS AND EAST TEXAS PROJECTS PARTNERSHIP BRINGS WORLD-CLASS PROJECT DEVELOPMENT CAPABILITIES, ACCELERATING SMACKOVER DEVELOPMENT PATH VANCOUVER, British Columbia, May 09, 2024 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV:SLI) (NYSE American:SLI) (FRA:S5L), a leading near-commercial lithium development company, today r...
Temenos Multifonds erweitert die Partnerschaft mit Citi Securities Ser...
Temenos Multifonds erweitert die Partnerschaft mit Citi Securities Services zur Konsolidierung globaler Fondsdienstleistungen in Multifonds SaaS Wechsel zu Multifonds SaaS ermöglicht Citi Securities Services die effiziente Verwaltung seines globalen Geschäfts auf einer einzigen Plattform GENF, Schweiz, May 09, 2024 (GLOBE NEWSWIRE) -- Heute gab Temenos (SIX: TEMN) bekannt, dass Multifonds seine Partnerschaft mit Citi Securities Services erweitert hat, um die derzeitige regionale Fondsbilanzierung in einem globalen SaaS-Bereitstellungsmodell in zu konsolidieren. Citi Securities Service...
Temenos Multifonds étend son partenariat avec Citi Securities Services...
Temenos Multifonds étend son partenariat avec Citi Securities Services en vue de consolider les services de fonds globaux sur le SaaS Multifonds La migration vers le SaaS Multifonds permet à Citi Securities Services de gérer efficacement ses activités mondiales sur une plateforme unique GENÈVE, Suisse, 09 mai 2024 (GLOBE NEWSWIRE) -- Temenos (SIX : TEMN) a annoncé, ce jour, que Multifonds avait étendu sa relation avec Citi Securities Services en vue de consolider son opération régionale actuelle de comptabilité des fonds dans un modèle opérationnel global sur livré en tant que SaaS. C...
Xometry Reports First Quarter 2024 Results
Xometry Reports First Quarter 2024 Results Q1 revenue increased 16% year-over-year to $123 million driven by marketplace growth of 24% year-over-year.Q1 gross profit increased 22% year-over-year driven by 37% growth in marketplace gross profit. Q1 marketplace gross margin increased 320 basis points year-over-year to a record 32.0%.Q1 Adjusted EBITDA loss of $7.5 million, a 37% improvement year-over-year driven by higher revenue, gross profit, and operating efficiencies.2024 growth initiatives include: expanding buyer and supplier networks; driving deeper enterprise engagement; expanding the...
Nevada Copper Files Financial Statements and MD&A for the Quarter Ende...
Nevada Copper Files Financial Statements and MD&A for the Quarter Ended March 31, 2024 YERINGTON, Nev., May 09, 2024 (GLOBE NEWSWIRE) -- Nevada Copper (TSX: NCU) (OTC: NEVDF) (FSE: ZYTA) (“Nevada Copper” or the “Company”) today announced that it has filed its consolidated interim financial statements and management's discussion and analysis ("MD&A") for the quarter ended March 31, 2024. These filings can be found on the Company’s website at and the Company’s SEDAR+ profile at . About Nevada Copper Nevada Copper (TSX: NCU) is the owner of the Pumpkin Hollow copper project located i...
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent...
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights Phase 2/3 pivotal trial design and protocol for HB-200 in combination with pembrolizumab for the first-line treatment of patients with HPV16+ recurrent or metastatic OPSCC aligns with U.S. Food and Drug Administration (FDA) feedbackHB-200 program received Priority Medicines (PRIME) designation from the European Medicines Agency (EMA)Received FDA clearance for Investigational New Drug (IND) application for HB-700 for the treatment of KRAS mutated cancers NEW YORK and VIENNA, May 09, 2024 (GLOBE NE...
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conf...
Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference WILMINGTON, Del., May 09, 2024 (GLOBE NEWSWIRE) -- (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Citizens JMP Life Sciences Conference, taking place in New York City on May 13 and 14. On Tuesday, May 14, at 1:00 p.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, and Jane Huang, M.D., President and Chief Medical Officer, will participate in a fireside chat. A live webcast of the fireside chat can be accessed and on t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.